The Longevity Centers of America Introduces Minimally Invasive NanoScope Needle Arthroscopy

Got story updates? Submit your updates here. ›

The Longevity Centers of America (LCOA) has expanded its regenerative medicine capabilities with the introduction of NanoScope Needle Arthroscopy, a minimally invasive diagnostic technology that utilizes a needle-sized camera to provide direct, real-time visualization inside joint spaces. This advanced system enables physicians to diagnose and potentially treat joint conditions in a single visit, streamlining the path from evaluation to intervention.

Why it matters

NanoScope technology addresses a critical gap in musculoskeletal diagnostics by allowing for direct observation of joint structures, which can help ensure treatment plans target the actual source of pain rather than relying on presumptive diagnoses from indirect imaging. The integration of this advanced diagnostic tool with LCOA's regenerative medicine approach aims to deliver more effective, non-surgical solutions for chronic joint pain and arthritis affecting millions of Americans.

The details

NanoScope Needle Arthroscopy uses a 1.9 millimeter needle-sized camera to provide direct visualization inside joint spaces, unlike traditional arthroscopy which requires surgical incisions. The minimally invasive procedure can be performed in an outpatient setting with local anesthesia, streamlining the path from evaluation to treatment. The enhanced diagnostic clarity helps physicians ensure therapies like regenerative injection treatments are precisely targeted to the affected joint structures.

• The Longevity Centers of America introduced NanoScope Needle Arthroscopy on January 29, 2026.

What’s next

Patients interested in learning whether NanoScope Needle Arthroscopy may be appropriate for their condition can schedule a consultation with The Longevity Centers of America.